Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.

Saphner T, Troxel AB, Tormey DC, Neuberg D, Robert NJ, Pandya KJ, Edmonson JH, Rosenbluth RJ, Abeloff MD.

J Clin Oncol. 1993 Aug;11(8):1529-35.

PMID:
8336191
2.

Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.

Michaud LB, Buzdar AU.

Drugs Aging. 2000 Apr;16(4):261-71. Review.

PMID:
10874521
3.
4.

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

Carlson RW, Henderson IC.

Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. Review.

PMID:
14535531
5.

Gn-RH agonists in breast and gynaecologic cancer treatment.

Nicholson RI, Walker KJ.

J Steroid Biochem. 1989 Oct;33(4B):801-4. Review.

PMID:
2532269
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.
8.

Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.

Cheer SM, Plosker GL, Simpson D, Wagstaff AJ.

Drugs. 2005;65(18):2639-55. Review.

PMID:
16392882
9.

Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?

Howell A, Howell SJ, Clarke R, Anderson E.

J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):227-37. Review.

PMID:
11850229
10.

Recent perspectives of endocrine therapy for breast cancer.

Utsumi T, Kobayashi N, Hanada H.

Breast Cancer. 2007;14(2):194-9. Review.

11.

Challenges in the endocrine management of breast cancer.

Mouridsen HT, Rose C, Brodie AH, Smith IE.

Breast. 2003 Aug;12 Suppl 2:S2-19. Review.

PMID:
14659138
12.

Current status of endocrine therapy for breast cancer.

Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.

Breast Cancer. 2003;10(2):105-11. Review.

PMID:
12736562
13.

Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.

Jonat W.

Br J Cancer. 2001 Nov;85 Suppl 2:1-5. Review. Erratum in: Br J Cancer 2002 Dec 2;87(12):1480.

15.

[Endocrinology of the peri- and postmenopausal period].

von Holst T.

Zentralbl Gynakol. 1991;113(5):237-44. Review. German. No abstract available.

PMID:
2058330
Items per page

Supplemental Content

Write to the Help Desk